Veterinary Medicine Information website

Albiotic Ενδομαστικό διάλυμα

Authorised
  • Lincomycin
  • Neomycin
Download as PDF

Product identification

Medicine name:
Albiotic Ενδομαστικό διάλυμα
Active substance:
  • Lincomycin
  • Neomycin
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Lincomycin
    330.00
    milligram(s)
    /
    1.00
    Syringe
  • Neomycin
    100.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary solution
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Milk
        84
        hour
      • Meat
        3
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RF03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Cyprus
Available in:
  • Cyprus
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet AD
Responsible authority:
  • Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
  • 7855
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 2/03/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 27/06/2022
Download